vs

Side-by-side financial comparison of Kymera Therapeutics, Inc. (KYMR) and Soluna Holdings, Inc (SLNH). Click either name above to swap in a different company.

Kymera Therapeutics, Inc. is the larger business by last-quarter revenue ($11.5M vs $8.4M, roughly 1.4× Soluna Holdings, Inc). Soluna Holdings, Inc runs the higher net margin — -284.7% vs -667.6%, a 382.9% gap on every dollar of revenue. On growth, Soluna Holdings, Inc posted the faster year-over-year revenue change (11.8% vs -55.3%). Soluna Holdings, Inc produced more free cash flow last quarter ($-6.8M vs $-60.6M). Over the past eight quarters, Kymera Therapeutics, Inc.'s revenue compounded faster (10.1% CAGR vs -8.8%).

Kymera Therapeutics is a clinical-stage biopharmaceutical company specialized in developing innovative targeted protein degradation therapies. It advances a diversified pipeline of drug candidates targeting previously undruggable proteins to address unmet medical needs in oncology, autoimmune and inflammatory diseases worldwide.

KYMR vs SLNH — Head-to-Head

Bigger by revenue
KYMR
KYMR
1.4× larger
KYMR
$11.5M
$8.4M
SLNH
Growing faster (revenue YoY)
SLNH
SLNH
+67.1% gap
SLNH
11.8%
-55.3%
KYMR
Higher net margin
SLNH
SLNH
382.9% more per $
SLNH
-284.7%
-667.6%
KYMR
More free cash flow
SLNH
SLNH
$53.7M more FCF
SLNH
$-6.8M
$-60.6M
KYMR
Faster 2-yr revenue CAGR
KYMR
KYMR
Annualised
KYMR
10.1%
-8.8%
SLNH

Income Statement — Q2 FY2025 vs Q3 FY2025

Metric
KYMR
KYMR
SLNH
SLNH
Revenue
$11.5M
$8.4M
Net Profit
$-76.6M
$-24.0M
Gross Margin
9.5%
Operating Margin
-736.8%
-92.5%
Net Margin
-667.6%
-284.7%
Revenue YoY
-55.3%
11.8%
Net Profit YoY
-82.1%
-233.2%
EPS (diluted)
$-0.95
$-1.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KYMR
KYMR
SLNH
SLNH
Q3 25
$8.4M
Q2 25
$11.5M
$6.2M
Q1 25
$22.1M
$5.9M
Q4 24
$7.4M
$8.3M
Q3 24
$7.5M
Q2 24
$25.6M
$9.7M
Q1 24
$10.3M
$12.5M
Q4 23
$47.9M
$10.1M
Net Profit
KYMR
KYMR
SLNH
SLNH
Q3 25
$-24.0M
Q2 25
$-76.6M
$-7.4M
Q1 25
$-65.6M
$-7.6M
Q4 24
$-70.8M
$-40.0M
Q3 24
$-7.2M
Q2 24
$-42.1M
$-10.9M
Q1 24
$-48.6M
$-5.3M
Q4 23
$-14.4M
$-6.7M
Gross Margin
KYMR
KYMR
SLNH
SLNH
Q3 25
9.5%
Q2 25
6.3%
Q1 25
5.7%
Q4 24
-360.8%
Q3 24
-39.1%
Q2 24
34.6%
Q1 24
45.4%
Q4 23
42.4%
Operating Margin
KYMR
KYMR
SLNH
SLNH
Q3 25
-92.5%
Q2 25
-736.8%
-107.6%
Q1 25
-336.8%
-120.9%
Q4 24
-1092.2%
-426.0%
Q3 24
-119.8%
Q2 24
-198.5%
-38.0%
Q1 24
-562.2%
3.2%
Q4 23
-40.3%
-23.9%
Net Margin
KYMR
KYMR
SLNH
SLNH
Q3 25
-284.7%
Q2 25
-667.6%
-119.9%
Q1 25
-296.7%
-127.3%
Q4 24
-956.9%
-483.8%
Q3 24
-95.5%
Q2 24
-164.0%
-112.4%
Q1 24
-472.0%
-41.9%
Q4 23
-30.0%
-66.2%
EPS (diluted)
KYMR
KYMR
SLNH
SLNH
Q3 25
$-1.14
Q2 25
$-0.95
$-0.93
Q1 25
$-0.82
$-1.21
Q4 24
$-0.89
$-7.14
Q3 24
$-1.56
Q2 24
$-0.58
$-3.62
Q1 24
$-0.69
$-2.62
Q4 23
$-0.25
$-1.99

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KYMR
KYMR
SLNH
SLNH
Cash + ST InvestmentsLiquidity on hand
$335.8M
Total DebtLower is stronger
$13.3M
Stockholders' EquityBook value
$971.5M
$14.5M
Total Assets
$1.1B
$152.0M
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KYMR
KYMR
SLNH
SLNH
Q3 25
Q2 25
$335.8M
Q1 25
$90.0M
Q4 24
$120.3M
Q3 24
Q2 24
$67.6M
Q1 24
$93.5M
Q4 23
$110.0M
Total Debt
KYMR
KYMR
SLNH
SLNH
Q3 25
$13.3M
Q2 25
$10.0M
Q1 25
$10.2M
Q4 24
$7.1M
Q3 24
$8.1M
Q2 24
$9.0M
Q1 24
Q4 23
Stockholders' Equity
KYMR
KYMR
SLNH
SLNH
Q3 25
$14.5M
Q2 25
$971.5M
$-19.5M
Q1 25
$786.2M
$-16.1M
Q4 24
$835.6M
$-12.5M
Q3 24
$20.9M
Q2 24
$684.9M
$24.4M
Q1 24
$711.2M
$21.5M
Q4 23
$395.0M
$26.5M
Total Assets
KYMR
KYMR
SLNH
SLNH
Q3 25
$152.0M
Q2 25
$1.1B
$92.0M
Q1 25
$918.3M
$90.0M
Q4 24
$978.0M
$88.0M
Q3 24
$97.3M
Q2 24
$826.0M
$98.7M
Q1 24
$868.3M
$90.6M
Q4 23
$575.8M
$91.3M
Debt / Equity
KYMR
KYMR
SLNH
SLNH
Q3 25
0.92×
Q2 25
Q1 25
Q4 24
Q3 24
0.39×
Q2 24
0.37×
Q1 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KYMR
KYMR
SLNH
SLNH
Operating Cash FlowLast quarter
$-59.9M
$-2.2M
Free Cash FlowOCF − Capex
$-60.6M
$-6.8M
FCF MarginFCF / Revenue
-527.9%
-81.4%
Capex IntensityCapex / Revenue
6.1%
55.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-250.5M
$-34.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KYMR
KYMR
SLNH
SLNH
Q3 25
$-2.2M
Q2 25
$-59.9M
$-1.1M
Q1 25
$-79.2M
$-177.0K
Q4 24
$-61.8M
$-5.1M
Q3 24
$61.0K
Q2 24
$-42.9M
$-7.3M
Q1 24
$-39.6M
$3.9M
Q4 23
$8.0M
$1.4M
Free Cash Flow
KYMR
KYMR
SLNH
SLNH
Q3 25
$-6.8M
Q2 25
$-60.6M
$-9.7M
Q1 25
$-79.6M
$-4.0M
Q4 24
$-62.7M
$-13.9M
Q3 24
$-3.4M
Q2 24
$-47.6M
$-7.6M
Q1 24
$-47.0M
$3.3M
Q4 23
$-3.6M
$1.2M
FCF Margin
KYMR
KYMR
SLNH
SLNH
Q3 25
-81.4%
Q2 25
-527.9%
-156.8%
Q1 25
-360.3%
-67.1%
Q4 24
-848.3%
-168.3%
Q3 24
-44.8%
Q2 24
-185.7%
-78.2%
Q1 24
-456.8%
26.5%
Q4 23
-7.5%
12.3%
Capex Intensity
KYMR
KYMR
SLNH
SLNH
Q3 25
55.2%
Q2 25
6.1%
139.0%
Q1 25
2.1%
64.2%
Q4 24
12.7%
107.0%
Q3 24
45.6%
Q2 24
18.3%
2.5%
Q1 24
72.0%
4.2%
Q4 23
24.3%
1.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KYMR
KYMR

Segment breakdown not available.

SLNH
SLNH

Data Hosting Revenue$5.3M62%
Cryptocurrency Mining Revenue$2.8M33%
Other$389.0K5%

Related Comparisons